Novo Nordisk Annual General Meeting Set for March 27
Ticker: NONOF · Form: 6-K · Filed: Feb 27, 2025 · CIK: 353278
Sentiment: neutral
Topics: agm, shareholder-meeting, corporate-governance
TL;DR
Novo Nordisk's AGM is March 27th, partly electronic. Shareholders vote on company direction.
AI Summary
Novo Nordisk A/S announced its Annual General Meeting will be held on March 27, 2024, at 2:00 PM CET at Bella Center. The meeting will be partially electronic, allowing shareholders to participate in person or electronically. The company is registered with the SEC under file number 333-82318.
Why It Matters
This meeting is where shareholders vote on company matters, potentially influencing Novo Nordisk's strategic direction and governance.
Risk Assessment
Risk Level: low — This filing is a routine announcement of an upcoming shareholder meeting and does not contain material financial or operational changes.
Key Players & Entities
- Novo Nordisk A/S (company) — Registrant
- March 27, 2024 (date) — Annual General Meeting date
- 2:00 PM CET (time) — Annual General Meeting time
- Bella Center (location) — Annual General Meeting venue
- 333-82318 (other) — SEC File Number
FAQ
When and where will the Novo Nordisk A/S Annual General Meeting be held?
The Annual General Meeting will be held on Thursday, March 27, 2024, at 14:00 (CET) at Bella Center.
How can shareholders participate in the Annual General Meeting?
Shareholders can choose between participating in person at Bella Center or electronically, as the meeting is partially electronic.
What is the SEC file number for Novo Nordisk A/S?
The SEC file number for Novo Nordisk A/S is 333-82318.
What is the primary purpose of this Form 6-K filing?
This Form 6-K filing serves as a report of foreign private issuer, specifically announcing the Notice for the Annual General Meeting of Novo Nordisk A/S.
What is the company's principal executive office address?
The company's principal executive offices are located at Novo Allé, DK-2880, Bagsvaerd, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 27, 2025 regarding NOVO NORDISK A S (NONOF).